|  Help  |  About  |  Contact Us

Publication : Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10.

First Author  Barreiro R Year  2004
Journal  J Immunol Volume  173
Issue  3 Pages  1519-25
PubMed ID  15265879 Mgi Jnum  J:92022
Mgi Id  MGI:3051471 Doi  10.4049/jimmunol.173.3.1519
Citation  Barreiro R, et al. (2004) Termination of antigen-specific immunity by CD95 ligand (Fas ligand) and IL-10. J Immunol 173(3):1519-25
abstractText  Following elimination of a foreign invader, the immune system must return to its normal quiescent levels. This process requires removal of reactive immune cells when they are no longer needed. We have explored the role of Fas/Fas ligand (FasL) in terminating immunity and demonstrate that mice defective in these proteins have prolonged immune responses. Studies demonstrate that termination of immunity occurs via the interaction of Fas(+) lymphoid cells with FasL(+) nonlymphoid cells at the site of Ag challenge. Our results also show that FasL is absent in quiescent tissue but is rapidly up-regulated during the local immune reaction. This occurs through the production of IL-10. Thus, FasL and IL-10 work in concert to eliminate inflammatory cells and control the duration of an immune response.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

7 Bio Entities

Trail: Publication

0 Expression